The antibody 34bE12, available from A Menarini Diagnostics, recognises cytokeratin 1, 5, 10 and 14. It reacts with squamous and adenosquamous cell carcinomas, while adenocarcinoma is negative. In normal tissue, 34bE12 stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchus. Thus, it is useful as a differential marker for squamous carcinoma and adenocarcinoma as well as for benign and malignant tumours of the prostate gland.
Other News
Latest Issues
Launch Diagnostics provides complete pathology solutions with a comprehensive portfolio of high-quality diagnostic reagents and instrumentation from world leading manufacturers to the Health Services of the United Kingdom. Our associated companies also provide solutions to France, Belgium, and Luxemburg through Launch Diagnostics SAS, to the...
Ghent Pathology 2025
ICC Ghent, Belgium
24-26 June, 2025
Distinguishing tumour tissue from normal tissue
Online
8 July, 2025
Introduction to direct immunofluorescence webinar
Online
10 July, 2025
Annual SHOT Symposium
Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025
Introduction to immunocytochemistry webinar
Online
15-16 July, 2025